New iron drug CTX001 put to the test in healthy people
NCT ID NCT07577817
First seen May 11, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This early-stage study tests an experimental drug called CTX001 in 72 healthy adults to see if it is safe and how the body processes it. The drug is being developed for conditions like anemia and chronic kidney disease where iron levels are off. Participants will take the drug by mouth, and researchers will monitor side effects and iron levels in the blood. No direct treatment benefit is expected for volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.